Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.41 |
| ▸ | ESR1 known ✓ | P03372 | 3/20 | 0.36 |
| ▸ | ESR2 known ✓ | Q92731 | 2/20 | 0.36 |
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.35 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.33 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.33 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.33 |
| ▸ | HTR2B known ✓ | P41595 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CFTR | P13569 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | NPY1R | P25929 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2582115 | 1.00 | CA2 (0.41) | CA2CA4CA5AESR1ESR2 | |
| SCHEMBL361668 | 0.97 | CA2 (0.43) | CA2CA4CA5AESR1ESR2 | |
| Bromide SCHEMBL2185231 | 0.93 | CA2 (0.41) | CA2CA4CA5AESR1ESR2 | |
| Fluoride SCHEMBL11191593 | 0.93 | CA2 (0.41) | CA2CA4CA5AESR1ESR2 | |
| Iodide SCHEMBL27336456 | 0.93 | CA2 (0.41) | CA2CA4CA5AESR1ESR2 | |
| SCHEMBL6316218 | 0.93 | CA2 (0.41) | CA2CA4CA5AESR1ESR2 | |
| Water SCHEMBL7532602 | 0.93 | CA2 (0.41) | CA2CA4CA5AESR1ESR2 | |
| SCHEMBL10710709 | 0.93 | CA2 (0.41) | CA2CA4CA5AESR1ESR2 | |
| Iodide SCHEMBL3694471 | 0.93 | CA2 (0.41) | CA2CA4CA5AESR1ESR2 | |
| Carbon Monoxide SCHEMBL10708053 | 0.89 | CA2 (0.40) | CA2CA4CA5AESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743505-A2 | NOVEL PHOTOSENSITIVE CARBON DIOXIDE BASED POLYCARBONATE DERIVATIVES AND METHOD FOR PREPARATION OF PHOTO-ANTIMICROBIAL POLYCARBONATE-BIOPLASTICIZER COMPOSITES AND THEIR USE | Universidade de Coimbra (PT) | 2026-05-20 | — | — | EP | claimed |
| EP-4731688-A1 | METHOD FOR THE PRODUCTION OF A HYDROXYL-GROUP TERMINATED OXAZOLIDINONE COMPOSITION | Covestro Deutschland AG (DE) | 2026-04-29 | — | — | EP | claimed |
| EP-4731689-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2026-04-29 | — | — | EP | claimed |
| US-12496575-B2 | Catalyst composition for cyclic carbonate production from CO2 and epoxides | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) | 2025-12-16 | — | — | US | claimed |
| US-20250362302-A1 | INTRACELLULAR LIGATION OF PHOTOCATALYSTS FOR PHOTO-RESPONSIVE, PROBE-MEDIATED PROTEIN LABELING | SEED THERAPEUTICS US INC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4448605-B1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | claimed |
| EP-4200351-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | claimed |
| EP-4200352-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | claimed |
| EP-4200353-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | claimed |
| US-12466913-B2 | Method for the production of a thermoplastic polyoxazolidinone | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-11 | — | — | US | claimed |
| US-8252891-B2 | Purification of polycarbonates | NOVOMER, INC. (US) | 2012-08-28 | — | — | US | claimed |
| US-20110201779-A1 | PURIFICATION OF POLYCARBONATES | NOVOMER, INC. (US) | 2011-08-18 | — | — | US | claimed |
| EP-2342258-A1 | PURIFICATION OF POLYCARBONATES | Novomer, Inc. (US) | 2011-07-13 | — | — | EP | claimed |
| WO-2010033703-A1 | PURIFICATION OF POLYCARBONATES | NOVOMER, INC. (US) | 2010-03-25 | — | — | WO | claimed |
| EP-0507616-B1 | Process for the preparation of trisubstituted ureas by reductive carbonylation | ARCO CHEM TECH (US) | 1996-02-07 | — | — | EP | claimed |
| EP-0273520-B1 | A COMPOSITION COMPRISING A POLYEPOXIDE AND A EPOXY ADVANCEMENT CATALYST, AND A PROCESS FOR PREPARING ADVANCED EPOXY RESINS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-09-22 | — | — | EP | claimed |
| US-5241118-A | Reacting nitroarene with carbon monoxide | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1993-08-31 | — | — | US | claimed |
| EP-0507616-A1 | Process for the preparation of trisubstituted ureas by reductive carbonylation | ARCO Chemical Technology, L.P. (US) | 1992-10-07 | — | — | EP | claimed |
| EP-0273520-A2 | A composition comprising a polyepoxide and a epoxy advancement catalyst, and a process for preparing advanced epoxy resins | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-07-06 | — | — | EP | claimed |
| US-4732958-A | BIS(TRIHYDROCARBYL PHOSPHINE) IMINIUM CATALYSTS | SHELL OIL COMPANY (US) | 1988-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12496575-B2 | Catalyst composition for cyclic carbonate production from CO2 and epoxides | CA3, INO80C, KCNN4 | CA2 5/4885ESR1 42/4885ESR2 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.